Michael M. Strage - 31 Dec 2021 Form 5 Insider Report for AngioGenex, Inc.

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
5
Accepted by SEC
16 Feb 2022, 15:40:36 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael M. Strage

Key filing fact

Michael M. Strage filed Form 5 for AngioGenex, Inc. on 16 Feb 2022.

Key facts

  • This page summarizes Michael M. Strage's Form 5 filing for AngioGenex, Inc..
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 16 Feb 2022, 15:40.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: +$4,050,295,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGGX transaction

Common Stock

Award

Transaction value
$4,050,000,000
Shares
+270,000
Change %
+4.7%
Price
$15000.00*
Shares after
6,043,014
Date
06 Jul 2021
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGGX transaction Derivative

Stock Option

Award

Transaction value
$262,500
Shares
+750,000
Change %
+225%
Price
$0.3500*
Shares after
1,083,333
Date
15 Jan 2019
Ownership
Direct
Underlying class
Common Stock
Underlying amount
750,000
Exercise price
$0.3500
AGGX transaction Derivative

Stock Option

Award

Transaction value
$32,500
Shares
+250,000
Change %
+23%
Price
$0.1300*
Shares after
1,333,333
Date
02 Sep 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
250,000
Exercise price
$0.1300
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .